Argenica Therapeutics Ltd (AU:AGN)
ASX:AGN
Australian Market
Holding AU:AGN?
Track your performance easily

Argenica Therapeutics Ltd (AGN) Financial Statements

7 Followers

Argenica Therapeutics Ltd Financial Overview

Argenica Therapeutics Ltd's market cap is currently ―. The company's EPS TTM is AU$-0.052; its P/E ratio is -14.20; Argenica Therapeutics Ltd is scheduled to report earnings on March 4, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21
Income Statement-
Total Revenue--
Gross Profit--
EBIT--
EBITDA--
Net Income Common Stockholders--
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 8.91MAU$ 7.14M
Total AssetsAU$ 9.04MAU$ 7.27M
Total DebtAU$ 0.00AU$ 0.00
Net DebtAU$ -8.91MAU$ -7.14M
Total LiabilitiesAU$ 735.91KAU$ 425.72K
Stockholders EquityAU$ 8.31MAU$ 6.85M
Cash Flow-
Free Cash Flow--
Operating Cash Flow--
Investing Cash Flow--
Financing Cash Flow--
Currency in AUD

Argenica Therapeutics Ltd Earnings and Revenue History

Argenica Therapeutics Ltd Debt to Assets

Argenica Therapeutics Ltd Cash Flow

Argenica Therapeutics Ltd Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis